Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
P09960
UPID:
LKHA4_HUMAN
Alternative names:
Leukotriene A(4) hydrolase; Tripeptide aminopeptidase LTA4H
Alternative UPACC:
P09960; B4DNQ9; F8VV40; Q6IAT6; Q9UCT7
Background:
Leukotriene A-4 hydrolase, also known as LTA4H, is a bifunctional zinc metalloenzyme with both epoxide hydrolase and aminopeptidase activities. It plays a crucial role in the conversion of LTA4 to leukotriene B4, a pro-inflammatory mediator, and inactivates the neutrophil attractant PGP, a bioactive fragment of collagen, through its aminopeptidase activity. Additionally, LTA4H is involved in the biosynthesis of anti-inflammatory lipid mediators, resolvin E1 and 18S-resolvin E1.
Therapeutic significance:
Understanding the role of Leukotriene A-4 hydrolase could open doors to potential therapeutic strategies, particularly in controlling inflammation and resolving inflammatory conditions.